US Stock MarketDetailed Quotes

TCBP TC BioPharm

Watchlist

0.8100
-0.0437-5.12%

Close Jul 22 16:00 ET

4.01MMarket Cap-41P/E (TTM)

TC BioPharm Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

Total revenue

94.30%3.84M

0.00%1.98M

0.00%494.67K

494.66K

-42.26%1.98M

494.67K

Operating revenue

--0

94.30%3.84M

0.00%1.98M

0.00%494.67K

--494.66K

-42.26%1.98M

--494.67K

Cost of revenue

Gross profit

Operating expense

-17.38%3.44M

-10.60%14.24M

3.52M

4.17M

72.03%15.93M

11.32%9.26M

33.78%2.82M

2.65M

-17.38%8.32M

2.11M

Selling and administrative expenses

-3.98%2.14M

-22.41%6.47M

--1.38M

--2.23M

168.14%8.34M

40.88%3.11M

111.76%1.18M

--1.05M

-26.80%2.21M

--555.56K

-General and administrative expense

-3.98%2.14M

-22.41%6.47M

--1.38M

--2.23M

168.14%8.34M

40.88%3.11M

111.76%1.18M

--1.05M

-26.80%2.21M

--555.56K

Research and development costs

-32.85%1.3M

2.36%7.77M

--2.14M

--1.93M

23.32%7.59M

-7.83%6.16M

4.99%1.65M

--1.6M

-22.45%6.68M

--1.57M

Other operating expenses

----

98.88%-6.38K

96.83%-435

--0

63.54%-569.2K

---13.71K

Operating profit

17.38%-3.44M

-17.84%-14.24M

-3.52M

-4.17M

-65.97%-12.08M

-14.86%-7.28M

-44.12%-2.33M

-2.16M

4.54%-6.34M

-1.61M

Net non-operating interest income expense

98.77%-83.03K

-96.40%-6.75M

-1,081.49%-3.44M

-2,692.96%-1.92M

-1.15M

-14.80%-291.03K

-68.81K

Non-operating interest income

----

-96.79%33

-98.78%5

--7

-95.30%1.03K

--410

Non-operating interest expense

----

-98.77%83.03K

----

96.40%6.75M

1,077.33%3.44M

2,676.43%1.92M

--1.15M

6.05%292.06K

--69.22K

Other net income (expense)

-99.71%9.06K

-53.64%7.33M

4.35M

3.13M

470.60%15.8M

-4.26M

-271.35K

Gain on sale of security

-99.64%11.45K

-50.00%7.97M

--4.98M

--3.15M

473.89%15.94M

---4.26M

---271.35K

----

Other non- operating income (expenses)

86.59%-2.39K

-360.19%-645.85K

---628.05K

---17.79K

---140.34K

----

Income before tax

-231.68%-3.43M

-130.61%-7M

688.49K

-1.03M

79.75%-3.03M

-126.00%-14.98M

-168.52%-4.52M

-7.3M

3.83%-6.63M

-1.68M

Income tax

72.31%-110.74K

36.70%-1.09M

-300K

-400K

-22.20%-1.72M

-20.10%-1.41M

-71.04%-620.09K

-274.94K

-41.87%-1.17M

-362.54K

Net income

-423.20%-3.32M

-349.68%-5.91M

988.49K

-634.91K

90.32%-1.31M

-148.74%-13.58M

-195.27%-3.9M

-7.03M

10.05%-5.46M

-1.32M

Net income continuous Operations

-423.20%-3.32M

-349.68%-5.91M

--988.49K

---634.91K

90.32%-1.31M

-148.74%-13.58M

-195.27%-3.9M

---7.03M

10.05%-5.46M

---1.32M

Minority interest income

Net income attributable to the parent company

-423.20%-3.32M

-349.68%-5.91M

988.49K

-634.91K

90.32%-1.31M

-148.74%-13.58M

-195.27%-3.9M

-7.03M

10.05%-5.46M

-1.32M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-423.20%-3.32M

-349.68%-5.91M

988.49K

-634.91K

90.32%-1.31M

-148.74%-13.58M

-195.27%-3.9M

-7.03M

10.05%-5.46M

-1.32M

Basic earnings per share

64.52%-2.2

49.74%-19.2

2.998

-6.2

94.50%-38.2

-257.03%-694.4918

-323.82%-199.5161

-359.5044

10.05%-194.5202

-47.076

Diluted earnings per share

64.52%-2.2

49.74%-19.2

2.998

-6.2

94.50%-38.2

-257.03%-694.4918

-323.82%-199.5161

-359.5044

10.05%-194.5202

-47.076

Dividend per share

Currency Unit

GBP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020
Total revenue	0	0	0	0	94.30%3.84M	0.00%1.98M	0.00%494.67K	494.66K	-42.26%1.98M	494.67K
Operating revenue	--0	--0	--0	--0	94.30%3.84M	0.00%1.98M	0.00%494.67K	--494.66K	-42.26%1.98M	--494.67K
Cost of revenue
Gross profit
Operating expense	-17.38%3.44M	-10.60%14.24M	3.52M	4.17M	72.03%15.93M	11.32%9.26M	33.78%2.82M	2.65M	-17.38%8.32M	2.11M
Selling and administrative expenses	-3.98%2.14M	-22.41%6.47M	--1.38M	--2.23M	168.14%8.34M	40.88%3.11M	111.76%1.18M	--1.05M	-26.80%2.21M	--555.56K
-General and administrative expense	-3.98%2.14M	-22.41%6.47M	--1.38M	--2.23M	168.14%8.34M	40.88%3.11M	111.76%1.18M	--1.05M	-26.80%2.21M	--555.56K
Research and development costs	-32.85%1.3M	2.36%7.77M	--2.14M	--1.93M	23.32%7.59M	-7.83%6.16M	4.99%1.65M	--1.6M	-22.45%6.68M	--1.57M
Other operating expenses	----	----	----	----	----	98.88%-6.38K	96.83%-435	--0	63.54%-569.2K	---13.71K
Operating profit	17.38%-3.44M	-17.84%-14.24M	-3.52M	-4.17M	-65.97%-12.08M	-14.86%-7.28M	-44.12%-2.33M	-2.16M	4.54%-6.34M	-1.61M
Net non-operating interest income expense		98.77%-83.03K			-96.40%-6.75M	-1,081.49%-3.44M	-2,692.96%-1.92M	-1.15M	-14.80%-291.03K	-68.81K
Non-operating interest income	----	----	----	----	----	-96.79%33	-98.78%5	--7	-95.30%1.03K	--410
Non-operating interest expense	----	-98.77%83.03K	----	----	96.40%6.75M	1,077.33%3.44M	2,676.43%1.92M	--1.15M	6.05%292.06K	--69.22K
Other net income (expense)	-99.71%9.06K	-53.64%7.33M	4.35M	3.13M	470.60%15.8M	-4.26M	-271.35K
Gain on sale of security	-99.64%11.45K	-50.00%7.97M	--4.98M	--3.15M	473.89%15.94M	---4.26M	---271.35K	----	----	----
Other non- operating income (expenses)	86.59%-2.39K	-360.19%-645.85K	---628.05K	---17.79K	---140.34K	----	----	----	----	----
Income before tax	-231.68%-3.43M	-130.61%-7M	688.49K	-1.03M	79.75%-3.03M	-126.00%-14.98M	-168.52%-4.52M	-7.3M	3.83%-6.63M	-1.68M
Income tax	72.31%-110.74K	36.70%-1.09M	-300K	-400K	-22.20%-1.72M	-20.10%-1.41M	-71.04%-620.09K	-274.94K	-41.87%-1.17M	-362.54K
Net income	-423.20%-3.32M	-349.68%-5.91M	988.49K	-634.91K	90.32%-1.31M	-148.74%-13.58M	-195.27%-3.9M	-7.03M	10.05%-5.46M	-1.32M
Net income continuous Operations	-423.20%-3.32M	-349.68%-5.91M	--988.49K	---634.91K	90.32%-1.31M	-148.74%-13.58M	-195.27%-3.9M	---7.03M	10.05%-5.46M	---1.32M
Minority interest income
Net income attributable to the parent company	-423.20%-3.32M	-349.68%-5.91M	988.49K	-634.91K	90.32%-1.31M	-148.74%-13.58M	-195.27%-3.9M	-7.03M	10.05%-5.46M	-1.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-423.20%-3.32M	-349.68%-5.91M	988.49K	-634.91K	90.32%-1.31M	-148.74%-13.58M	-195.27%-3.9M	-7.03M	10.05%-5.46M	-1.32M
Basic earnings per share	64.52%-2.2	49.74%-19.2	2.998	-6.2	94.50%-38.2	-257.03%-694.4918	-323.82%-199.5161	-359.5044	10.05%-194.5202	-47.076
Diluted earnings per share	64.52%-2.2	49.74%-19.2	2.998	-6.2	94.50%-38.2	-257.03%-694.4918	-323.82%-199.5161	-359.5044	10.05%-194.5202	-47.076
Dividend per share
Currency Unit	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall